Financhill
Buy
57

FHI Quote, Financials, Valuation and Earnings

Last price:
$41.47
Seasonality move :
4.08%
Day range:
$40.89 - $41.59
52-week range:
$31.24 - $43.92
Dividend yield:
2.92%
P/E ratio:
13.35x
P/S ratio:
2.09x
P/B ratio:
3.16x
Volume:
303.1K
Avg. volume:
564.2K
1-year change:
21.59%
Market cap:
$3.4B
Revenue:
$1.6B
EPS (TTM):
$3.11

Analysts' Opinion

  • Consensus Rating
    Federated Hermes has received a consensus rating of Hold. The company's average rating is a Hold based on 3 Buy ratings, 5 Hold ratings, and 0 Sell ratings.
  • Price Target Upside
    According to analysts' consensus price target of $42.88, Federated Hermes has an estimated upside of 3.59% from its current price of $41.51.
  • Price Target Downside
    According to analysts, the lowest downside price target is $37.00 representing 100% downside risk from its current price of $41.51.

Fair Value

  • According to the consensus of 8 analysts, Federated Hermes has 3.59% upside to fair value with a price target of $42.88 per share.

FHI vs. S&P 500

  • Over the past 5 trading days, Federated Hermes has overperformed the S&P 500 by 0.02% suggesting its relative strength compared to the major market average is strong at this time.

Share Buyback

  • Federated Hermes does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.

Revenue Growth

  • Federated Hermes has grown year-over-year revenues for 1 quarter straight. In the most recent quarter Federated Hermes reported revenues of $408.5M.

Earnings Growth

  • Federated Hermes has grown year-over-year earnings for 1 quarter straight. In the most recent quarter Federated Hermes reported earnings per share of $1.06.
Enterprise value:
3.3B
EV / Invested capital:
2.20x
Price / LTM sales:
2.09x
EV / EBIT:
8.18x
EV / Revenue:
2.04x
PEG ratio (5yr expected):
13.70x
EV / Free cash flow:
9.50x
Price / Operating cash flow:
9.70x
Enterprise value / EBITDA:
7.74x
Gross Profit (TTM):
$1.1B
Return On Assets:
13.01%
Net Income Margin (TTM):
16.62%
Return On Equity:
23.19%
Return On Invested Capital:
17.79%
Operating Margin:
28.22%
Trailing 12 Months Fiscal Quarters
Period Ending 2022-09-30 2023-09-30 2024-09-30 2023-09-30 2024-09-30
Income Statement
Revenue $1.4B $1.6B $1.6B $402.7M $408.5M
Gross Profit $880.7M $1B $1.1B $263.5M $272.4M
Operating Income $384.8M $393.7M $433.4M $104.9M $115.2M
EBITDA $381.8M $409.5M $422.1M $110.2M $131.5M
Diluted EPS $2.74 $3.08 $3.11 $0.86 $1.06
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Balance Sheet
Current Assets $569.4M $478M $630.3M $711.7M $723.2M
Total Assets $2B $1.9B $2B $2.1B $2B
Current Liabilities $234.4M $234.7M $238.9M $255.6M $263.1M
Total Liabilities $852.2M $741.6M $946.6M $909.7M $900.6M
Total Equity $1.2B $1.2B $1B $1.2B $1.1B
Total Debt $90M $102.2M $397.5M $347.8M $348M
Trailing 12 Months Fiscal Quarters
Period Ending 2022-09-30 2023-09-30 2024-09-30 2023-09-30 2024-09-30
Cash Flow Statement
Cash Flow Operations $261M $314.6M $349.5M $105.6M $117.1M
Cash From Investing -$3.5M -$22.5M -$16.3M $1.3M -$8.3M
Cash From Financing -$126.1M -$230.1M -$351.6M -$68.4M -$51.5M
Free Cash Flow $254.2M $308.5M $343.9M $103.6M $120.2M
FHI
Sector
Market Cap
$3.4B
$700.3M
Price % of 52-Week High
94.51%
88.31%
Dividend Yield
2.92%
2.2%
Shareholder Yield
11.83%
3.87%
1-Year Price Total Return
21.59%
7.75%
Beta (5-Year)
1.155
0.737
Dividend yield:
2.92%
Annualized payout:
$1.11
Payout ratio:
69.13%
Growth streak:
1 years

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Technicals

8-day SMA
Buy
Level $41.36
200-day SMA
Buy
Level $35.96
Bollinger Bands (100)
Buy
Level 34.47 - 41.53
Chaikin Money Flow
Buy
Level 33.3M
20-day SMA
Sell
Level $42.15
Relative Strength Index (RSI14)
Sell
Level 48.57
ADX Line
Buy
Level 24.22
Williams %R
Neutral
Level -64.2105
50-day SMA
Buy
Level $41.18
MACD (12, 26)
Sell
Level -0.04
25-day Aroon Oscillator
Sell
Level -40
On Balance Volume
Neutral
Level 88.6M

Financial Scores

Buy
Altman Z-Score (Annual)
Level (4.2932)
Buy
CA Score (Annual)
Level (0.894)
Buy
Beneish M-Score (Annual)
Level (-2.2569)
Buy
Momentum Score
Level (8)
Buy
Ohlson Score
Level (-1.4834)
Buy
Piotroski F Score (Annual)
Level (7)
Buy
Quality Ratio Score
Level (6)
Buy
Fundamental Score
Level (10)

Revenue Forecast

Earnings per Share Forecast

Company Profile

Federated Hermes provides asset-management services for institutional and individual investors. The firm had $800 billion in managed assets at the end of September 2024, composed of equity (10%), multi-asset (less than 1%), fixed-income (12%), alternative (3%), and money market (74%) funds. The firm's cash-management operations are expected to generate around 51% of Federated's revenue this year, compared with 29%, 12%, and 7%, respectively, for the equity, fixed-income, and alternatives/multi-asset operations. The company's products are distributed via trust banks, wealth managers, and retail broker/dealers (65% of AUM), institutional investors (26%), and international clients (9%).

Stock Forecast FAQ

In the current month, FHI has received 3 Buy ratings 5 Hold ratings, and 0 Sell ratings. The FHI average analyst price target in the past 3 months is $42.88.

  • Where Will Federated Hermes Stock Be In 1 Year?

    According to analysts, the consensus estimate is that Federated Hermes share price will rise to $42.88 per share over the next 12 months.

  • What Do Analysts Say About Federated Hermes?

    Analysts are divided on their view about Federated Hermes share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Federated Hermes is a Sell and believe this share price will drop from its current level to $37.00.

  • What Is Federated Hermes's Price Target?

    The price target for Federated Hermes over the next 1-year time period is forecast to be $42.88 according to 8 Wall Street analysts, 3 of them rate the stock a Buy, 0 rate the stock a Sell, and 5 analysts rate the stock a Hold.

  • Is FHI A Buy, Sell Or Hold?

    According to Wall Street analysts, the consensus rating for Federated Hermes is a Hold. 5 of 8 analysts rate the stock a Hold at this time.

  • How Can I Buy Shares Of FHI?

    You can purchase shares of Federated Hermes via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Federated Hermes shares.

  • What Is The Federated Hermes Share Price Today?

    Federated Hermes was last trading at $41.47 per share. This represents the most recent stock quote for Federated Hermes. Yesterday, Federated Hermes closed at $41.51 per share.

  • How To Buy Federated Hermes Stock Online?

    In order to purchase Federated Hermes stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

How High Will Airbnb Stock Go?
How High Will Airbnb Stock Go?

Airbnb, Inc. (NASDAQ:ABNB) share price has seen substantial turbulence over…

Why Is SoundHound AI Stock Up So Much?
Why Is SoundHound AI Stock Up So Much?

Like many companies improving AI technologies and exploring ways to…

Is The Santa Claus Rally The Gift That Keeps Giving?
Is The Santa Claus Rally The Gift That Keeps Giving?

Remember the horror of 2008 when the Great Recession hit…

Stock Ideas

Buy
65
Is AAPL Stock a Buy?

Market Cap: $3.9T
P/E Ratio: 43x

Buy
56
Is NVDA Stock a Buy?

Market Cap: $3.4T
P/E Ratio: 118x

Buy
57
Is MSFT Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 37x

Alerts

Buy
64
ARQQ alert for Dec 27

Arqit Quantum [ARQQ] is up 49.85% over the past day.

Buy
64
QMCO alert for Dec 27

Quantum [QMCO] is up 49.62% over the past day.

Buy
65
ALGS alert for Dec 27

Aligos Therapeutics [ALGS] is up 10.88% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock